Research and Clinical Trials

Title  
MK-3475-361: A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma
Brief Description  
To compare PFS using RECIST 1.1 as assessed by BICR and OS in PD-L1 positive subjects and all subjects between the following treatment comparisons:(a) Pembrolizumab + chemotherapy versus chemotherapy; (b) Pembrolizumab versus chemotherapy
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Kidney
Status  
OPEN
Start Date  
02/02/2017
IRB Number  
00019769
Principal Investigator  
Burgess, Earle Frederick
Contact Name  
Gretchen Lee Nobis

For More Information, Contact  Gretchen  Lee, Nobis
Phone:  980-442-2305 Fax:    
Email:  gretchen.nobis@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close